- Home
- ECOR vs THTX Comparison
ECOR vs THTX Comparison
Compare ECOR & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- THTX
- Stock Information
- Founded
- ECOR 2005
- THTX 1993
- Country
- ECOR United States
- THTX Canada
- Employees
- ECOR N/A
- THTX N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- THTX Health Care
- Exchange
- ECOR Nasdaq
- THTX Nasdaq
- Market Cap
- ECOR 57.5M
- THTX N/A
- IPO Year
- ECOR 2018
- THTX N/A
- Fundamental
- Price
- ECOR $5.66
- THTX $1.48
- Analyst Decision
- ECOR Strong Buy
- THTX Hold
- Analyst Count
- ECOR 2
- THTX 1
- Target Price
- ECOR $25.50
- THTX N/A
- AVG Volume (30 Days)
- ECOR 212.1K
- THTX 3.0M
- Earning Date
- ECOR 05-07-2025
- THTX 04-09-2025
- Dividend Yield
- ECOR N/A
- THTX N/A
- EPS Growth
- ECOR N/A
- THTX N/A
- EPS
- ECOR N/A
- THTX N/A
- Revenue
- ECOR $25,182,000.00
- THTX $85,866,000.00
- Revenue This Year
- ECOR $32.20
- THTX $3.57
- Revenue Next Year
- ECOR $46.27
- THTX $7.73
- P/E Ratio
- ECOR N/A
- THTX N/A
- Revenue Growth
- ECOR 57.09
- THTX 5.02
- 52 Week Low
- ECOR $5.24
- THTX $1.08
- 52 Week High
- ECOR $19.49
- THTX $2.18
- Technical
- Relative Strength Index (RSI)
- ECOR 19.79
- THTX 45.70
- Support Level
- ECOR $6.04
- THTX $1.31
- Resistance Level
- ECOR $7.05
- THTX $1.52
- Average True Range (ATR)
- ECOR 0.62
- THTX 0.14
- MACD
- ECOR 0.02
- THTX -0.01
- Stochastic Oscillator
- ECOR 11.63
- THTX 20.99
Stock Price Comparison Chart: ECOR vs THTX
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.